moderna
OpenCalais Metadata: Ticker
OpenCalais Metadata: LegalName
UK asks regulator to study AstraZeneca vaccine
The British government said on Nov. 27 it has asked its independent medicines regulator to assess AstraZeneca's coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.
- Read more about UK asks regulator to study AstraZeneca vaccine
- Log in to post comments
Vučić announced: Meeting scheduled, main topic - urgent procurement of vaccines PHOTO
"Urgent procurement of vaccines is the only topic of today's meeting with representatives of the Institute of Virology, Vaccines and Serums 'Torlak', the Institute of Public Health of Serbia 'Dr Milan Jovanovic Batut', the Drug Agency and the RHIF," Vucic said, along with photos from the meeting on the official account of "Budunostsrbije" on Instagram.
EU reaches deal with Moderna on Covid-19 vaccine supply, says source
The European Union has reached a deal with US biotech firm Moderna for the supply of its Covid-19 vaccine candidate, an EU official told Reuters on Tuesday.
Last week Moderna said its experimental vaccine was 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.
WHO chief sees 'light at the end of long, dark tunnel'
With current vaccine developments, the light at the end of the COVID-19 tunnel is growing brighter, the World Health Organization (WHO) chief said on Nov. 23.
WHO Director-General Tedros Ghebreyesus gave an upbeat assessment on vaccine development after recent data showed that more COVID-19 cases had been reported in a recent 4 weeks than in first 6 months of the pandemic.
COVID-19 Vaccine: AstraZeneca and Oxford University Seek Approval after 'Effective' Trials
British drugs group AstraZeneca and the University of Oxford said on Monday they will seek regulatory approval for their coronavirus vaccine after "effective" trials, in the latest potential boost to curbing the global outbreak.
The partners announced that while the vaccine showed an average 70-percent effectiveness, the level jumped to 90 percent depending on dosage.
AstraZeneca, Oxford say virus vaccine shows 70% efficacy
British drugs group AstraZeneca and the University of Oxford on Nov. 23 said their jointly-developed vaccine against COVID-19 has shown "an average efficacy of 70 percent" in trials.
US hopes to start virus vaccines in December as pandemic surges
The United States hopes to begin coronavirus vaccinations in early December, a top government health official said on Nov. 22, the latest positive news to emerge even as cases surge across the worst-hit nation and elsewhere around the globe.